Literature DB >> 16874672

Minimized weight gain between hemodialysis contributes to a reduced risk of death.

B G Stegmayr1, M Brannstrom, S Bucht, E Dimeny, A Ekspong, B Granroth, K C Grontoft, H Hadimeri, B Holmberg, B Ingman, B Isaksson, G Johansson, K Lindberger, L Lundberg, O Lundstrom, L Mikaelsson, M Mortzell, E Olausson, B Persson, L Svensson, A M Wikdahl.   

Abstract

UNLABELLED: The risk of death is higher in dialysis patients compared to age matched healthy subjects, the main reason being cardiovascular. This prospective study investigated if the extent of ultrafiltration was of importance for the outcome.
MATERIAL AND METHODS: 88 hemodialysis patients were included and followed prospectively. The outcome was registered in regard to death, acute myocardial infarction or coronary vascular intervention. The extent of ultrafiltration needed at dialysis was calculated as a mean during the observation period as were other variables. The mean extent of ultrafiltration was compared for patients who had survived without end-points (group 1, n=53) versus those who reached any end-point during the period (group 2, n=35).
RESULTS: In total, 40% of the patients reached end-point during the observation period. There was no difference at baseline between the groups in regard to age, prevalence of diabetes mellitus or history of previous cardiovascular disease, KT/V, residual renal function ultrafiltration need, C-reactive protein, s-albumin, cholesterol, LDL-cholesterol, HDL-cholesterol, appetite or wellbeing, while triglyceride was lower in group 2 (p=0.035). The observation period for group 1 was at a mean 24.7 months (SD13.1) and for those in group 2 at a mean 13.8 (+/-11.7 months, p<0.001). Patients representing group 1 at 24 and 30 months had less need of ultrafiltration than those in group 2. Thus, the need of ultrafiltration was about 27% lower at 24 months (for 29 persons in group 1: 3.63+/-1.93 weight% versus 4.97+/-1.70 weight% for 9 patients from group 2, p=0.046) and 46% at 30 months (for 18 from group 1: 3.48+/-1.95 versus 6.45+/-1.55 for 3 from group 2, p=0.030). C-reactive protein did not differ significantly between the groups during the period.
CONCLUSION: After a prolonged period of 24 months the extent of ultrafiltration need seems to be important for the outcome of the patients. Thereby those with higher need of ultrafiltration had worse prognosis. It seems important to motivate patients to reduce the extent of fluid intake between dialysis to prolong survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16874672     DOI: 10.1177/039139880602900705

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  9 in total

1.  Intradialytic hypotension and risk of cardiovascular disease.

Authors:  Bergur V Stefánsson; Steven M Brunelli; Claudia Cabrera; David Rosenbaum; Emmanuel Anum; Karthik Ramakrishnan; Donna E Jensen; Nils-Olov Stålhammar
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 8.237

2.  Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain.

Authors:  Jennifer E Flythe; Gary C Curhan; Steven M Brunelli
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-14       Impact factor: 8.237

3.  Shorter dialysis times are associated with higher mortality among incident hemodialysis patients.

Authors:  Steven M Brunelli; Glenn M Chertow; Elizabeth D Ankers; Edmund G Lowrie; Ravi Thadhani
Journal:  Kidney Int       Date:  2010-01-20       Impact factor: 10.612

4.  A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients.

Authors:  Claudia Cabrera; Steven M Brunelli; David Rosenbaum; Emmanuel Anum; Karthik Ramakrishnan; Donna E Jensen; Nils-Olov Stålhammar; Bergur V Stefánsson
Journal:  BMC Nephrol       Date:  2015-07-22       Impact factor: 2.388

5.  NT-pro-BNP as marker for cardiac strain that may be caused by high-output arteriovenous shunting in a haemodialysis patient. A case report.

Authors:  Michaela Wärja; Emelie Laveborn; Michael Ott; Andreas P Jonsson; Bernd Stegmayr
Journal:  BMC Nephrol       Date:  2020-12-21       Impact factor: 2.388

6.  Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment.

Authors:  Ji Yong Jung; Kyung Don Yoo; Eunjeong Kang; Hee Gyung Kang; Su Hyun Kim; Hyoungnae Kim; Hyo Jin Kim; Tae-Jin Park; Sang Heon Suh; Jong Cheol Jeong; Ji-Young Choi; Young-Hwan Hwang; Miyoung Choi; Yae Lim Kim; Kook-Hwan Oh
Journal:  Kidney Res Clin Pract       Date:  2021-12-10

7.  Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment.

Authors:  Ji Yong Jung; Kyung Don Yoo; Eunjeong Kang; Hee Gyung Kang; Su Hyun Kim; Hyoungnae Kim; Hyo Jin Kim; Tae-Jin Park; Sang Heon Suh; Jong Cheol Jeong; Ji-Young Choi; Young-Hwan Hwang; Miyoung Choi; Yae Lim Kim; Kook-Hwan Oh
Journal:  Kidney Res Clin Pract       Date:  2021-12-10

Review 8.  Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment.

Authors:  Ji Yong Jung; Kyung Don Yoo; Eunjeong Kang; Hee Gyung Kang; Su Hyun Kim; Hyoungnae Kim; Hyo Jin Kim; Tae-Jin Park; Sang Heon Suh; Jong Cheol Jeong; Ji-Young Choi; Young-Hwan Hwang; Miyoung Choi; Yae Lim Kim; Kook-Hwan Oh
Journal:  Korean J Intern Med       Date:  2022-06-03       Impact factor: 3.165

9.  Interdialytic weight gain of less than 2.5% seems to limit cardiac damage during hemodialysis.

Authors:  Junko Goto; Ulf Forsberg; Per Jonsson; Kenichi Matsuda; Bo Nilsson; Kristina Nilsson Ekdahl; Michael Y Henein; Bernd G Stegmayr
Journal:  Int J Artif Organs       Date:  2020-12-18       Impact factor: 1.595

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.